| Ytd | 24.90% | |
| 1y | 63.76% |
| Open | 57.92 | Prev Close | 57.92 | Low | 57.55 | High | 59.56 | Mkt Cap | 8.96B |
| Vol | 1.47M | Avg Vol | 2.24M | EPS | -0.70 | P/E | N/A | Forward P/E | 24.59 |
| Beta | 1.22 | Short Ratio | 6.29 | Inst. Own | 95.37% | Dividend | 0.20 | Div Yield | 0.35 |
| Ex Div Date | 09-21 | Earning | 11-03 | 50-d Avg | 58.83 | 200-d Avg | 49.61 | 1yr Est | 63.67 |
BRKR News
BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despi
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the pri
On October 06, 2026, Bruker Corp (BRKR) shares fell 5.3% to a current price of $60.50, moving within
BERLIN--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced a seminal bioRx
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the
Bruker Corporation (NASDAQ: BRKR - Get Free Report) shares hit a new 52-week high during mid-day tra
You can't buy Neuralink stock yet, but its supply chain is already public. Here are the brain-comput
Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price tar
Leerink Partners analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises
At the Human Proteome Organization World Congress 2026, [url="]Bruker Corporation[/url] (Nasdaq: BRK
SINGAPORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the Human Proteome Organization World Congress 2026,
Bruker NASDAQ: BRKR CFO Gerald Herman said the company's second-quarter results reflected stronger-t
Bruker Corporation (BRKR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Bruker Corporation (NASDAQ:BRKR) today announced a multi-system order from the University of Califor
BERKELEY, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced
Bruker Corporation (BRKR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transc
U.S. stocks mixed as Nasdaq rises; LuxExperience jumps 13.5% on strong sales, while Einride, Forgent
UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target
Bruker Corporation (BRKR) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
[url="]Bruker Corporation[/url] (Nasdaq: BRKR) announced today that its senior leadership will prese
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today
Bruker Energy & Supercon Technologies (BEST), a segment of Bruker Corporation (NASDAQ:BRKR), and
Bruker Energy and Supercon Technologies (BEST), a segment of [url="]Bruker Corporation[/url] (Nasdaq
HANAU, Germany--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Energy & Supercon Technologies (BEST), a seg
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
10x Genomics won a $4.8 million patent infringement lawsuit against Qiagen subsidiary Parse Bioscien
Deutsche Bank AG acquired a new stake in Bruker Corporation (NASDAQ: BRKR) in the second quarter, ac
Bank of New York Mellon Corp acquired a new stake in Bruker Corporation (NASDAQ: BRKR) during the un
Citigroup analyst Brendan Digan maintains Bruker (NASDAQ:BRKR) with a Neutral and lowers the pric
The S&P 500 and Dow set records as Palantir and Caterpillar earnings powered chips higher, while
Gainers Autonomix Medical (NASDAQ:AMIX) stock rose 415.3% to $18.81 during Tuesday's regular se
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock moved upwards by 55.4% to $0.44 during Tuesday'
Bruker (NASDAQ:BRKR) affirms FY2026 Adj EPS guidance from $2.10-$2.15 to $2.10-$2.15 vs $2.12 analys
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.49 per share which beat the analyst consensus
Gainers iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-mar
The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehens
Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the p
Leerink Partners analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises
Guggenheim analyst Subbu Nambi maintains Bruker (NASDAQ:BRKR) with a Buy and raises the price tar
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the pri
Bruker CorporationCommon StockPreferred StockDebt SecuritiesWarrantsUnitsDepositary SharesSubscripti
At ASM Microbe 2026, Bruker Corporation's (Nasdaq: BRKR) Microbiology & Infection Diagnostic
Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry
World's highest-field MRI system provides leading disease biology research capabilitiesBruker Co
UBS analyst Dan Leonard maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the price target
Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Neutral and raises the p
TD Cowen analyst Kyle Boucher maintains Bruker (NASDAQ:BRKR) with a Hold and raises the price tar
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the pri
